What is IBRX's dilution risk score?

IBRX has a latest available DilutionScore record of 35/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for IBRX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for IBRX?

DilutionWatch tracks 25 SEC filing types for IBRX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect IBRX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For IBRX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for IBRX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for IBRX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

IBRX Dilution Risk Score: 35/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

32

💰 Cash Runway

40

📊 Float Risk

67

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for IBRX.

🔔 Track IBRX — Get forecast alerts →

Market Data

Market Cap$7.88B

Shares Outstanding1.06B

Float394.04M

Cash$357.37M

Debt$884.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 37.1% shares (2026Q1 vs prior)

396 institutional holders · 242.19M shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 30.26M shares

#2 BlackRock, Inc. 26.35M shares

#3 STATE STREET CORP 17.71M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest129.00M

Days to Cover14.5

% of Float32.7%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

xbrl XBRL WARRANT 2025-12-31

4 INSIDER TRANSACTION 2026-06-26

4 INSIDER TRANSACTION 2026-06-10

Full SEC filing analysis available with free account →

Recent News

IBRX Stock Heads For Best Week In Over 2 Months After Chairman Soon Shiong’s Can Stocktwits · Aug 27

SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Ca Stocktwits · Aug 27

SLS, IBRX Catch The Eye Of A Major US Pension Fund — And Big Clinical Catalysts Stocktwits · Aug 26

Factual IBRX Dilution Snapshot

ImmunityBio, Inc. (IBRX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for IBRX: 4 on 2026-06-26; 4 on 2026-06-10; 4 on 2026-06-10.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.